Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PAC-1 for Treatment of Refractory, Metastatic Kidney Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03927248
Recruitment Status : Not yet recruiting
First Posted : April 25, 2019
Last Update Posted : October 17, 2019
Sponsor:
Information provided by (Responsible Party):
HealthPartners Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : May 2021